← FDA Drug Approvals (Drugs@FDA)
THIOTEPA
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MEITHEAL · Approved 2023-12-26
Drug application
- FDA Application #
ANDA216037- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- THIOTEPA
- Generic name
- THIOTEPA
- Active ingredients
- THIOTEPA
- Dosage form
- POWDER
- Route
- INTRACAVITARY, INTRAVENOUS, INTRAVESICAL
- Marketing status
- Prescription
- Sponsor
- MEITHEAL
- Manufacturer
- Meitheal Pharmaceuticals Inc
- First approval
- 2023-12-26
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown